Please assess the completion status of the following clinical trial:

Trial Title: Use of Pap Smear Derived Cells to Analyze the Expression of SLC6A14 and GPR81 Genes

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Women who present to the TTUHSC Lubbock OBGYN Clinics for exams and are having cervical Pap smear collected as part of the evaluations.~2. Women who have vaginal discharge will be also included in the study if they are having cervical Pap smear collected as part of their exam.~3. Age criteria 21yr- 65yrs or more -per ASCCP guidelines for Pap smears.~4. Patients on any medications will also be included- medications have no effect on Pap smear results.~Exclusion Criteria:~1. Women who have had a hysterectomy.~2. Women having vaginal Pap smears.~3. Women with known HIV.

- Gender: FEMALE
- Minimum Age: 21 Years
- Maximum Age: 90 Years
- Healthy Volunteers: t

Study Arms:
- Normal Pap smears (Type: None): This is the control group.
- Abnormal Pap smears (Type: None): This is the case group.

Based on this trial design, predict the completion outcome and termination type (if applicable).